growth failure


Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia, Wikipedia.
Related to growth failure: failure to thrive

growth failure

a lack of normal physical and psychological development that results from genetic, nutritional, pathological, or psychosocial factors. See also failure to thrive, maternal deprivation syndrome.

growth failure

 
1. Dysplasia–Pediatrics, see there.
2. Failure to thrive, see there.
References in periodicals archive ?
As a result of difficulty in feeding casued by obstruction calorie intake decreases, the rate of increase in weight decreases in the short term, the rate of increase in height decreases in the long term and growth failure may develop (24).
Furthermore, they noted that attempts to mitigate growth failure were futile.
Studies have shown that children with moderate to severe cerebral palsy and growth failure require two to twelve times as long to eat a pureed meal as their peers without disabilities.
Specifically, PROLOR's Human Growth Hormone, used for the long-term treatment of children and adults with growth failure, is scheduled for Phase III trials and has a claimed potential market opportunity of $3 billion.
Norditropin is used to treat children with growth failure caused by very low or no production of growth hormone and in adults who don't produce enough growth hormone.
i) In the United States, 18,000 to 20,000 children receive recombinant growth hormone to treat growth failure.
In an animal model that replicates the severe growth failure and liver dysfunction seen in patients with LAL Deficiency, SBC-102 normalized growth and corrected liver abnormalities," said Anthony Quinn, M.
Norditropin(R) (somatropin [rDNA origin] injection) is indicated for the treatment of children with short stature associated with Noonan syndrome, treatment of children with short stature associated with Turner Syndrome, treatment of children with growth failure due to inadequate secretion of endogenous growth hormone, and treatment of short stature in children born SGA with no catch-up growth by age 2.
TEV-TROPIN([R]) is indicated only for the treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone (GH).
The drug, approved in the United States in December 2005 for the treatment of children with growth failure due to severe primary IGF-I deficiency, is currently being investigated in Myotonic Muscular Dystrophy (MMD) and Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease.
In children, when there is a deficiency or absence of growth hormone, growth failure occurs.